Somewhat Positive News Coverage Somewhat Unlikely to Impact Orthopediatrics (KIDS) Share Price

Media coverage about Orthopediatrics (NASDAQ:KIDS) has trended somewhat positive this week, according to Accern. The research group identifies positive and negative media coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Orthopediatrics earned a news impact score of 0.15 on Accern’s scale. Accern also gave news headlines about the company an impact score of 46.5523820986901 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

Orthopediatrics (NASDAQ KIDS) traded down $0.62 during mid-day trading on Thursday, reaching $16.65. The company had a trading volume of 11,000 shares, compared to its average volume of 31,305. Orthopediatrics has a one year low of $15.85 and a one year high of $23.00. The company has a debt-to-equity ratio of -0.38, a current ratio of 2.78 and a quick ratio of 1.00.

A number of research firms have recently commented on KIDS. William Blair began coverage on Orthopediatrics in a research note on Monday, November 6th. They issued an “outperform” rating for the company. Stifel Nicolaus assumed coverage on Orthopediatrics in a research note on Monday, November 6th. They issued a “buy” rating and a $23.00 target price for the company. BTIG Research assumed coverage on Orthopediatrics in a research report on Monday, November 6th. They set a “buy” rating and a $24.00 price objective for the company. Piper Jaffray Companies assumed coverage on Orthopediatrics in a research report on Monday, November 6th. They set an “overweight” rating and a $24.00 price objective for the company. Finally, BidaskClub lowered Orthopediatrics from a “hold” rating to a “sell” rating in a research report on Tuesday, January 9th. Two equities research analysts have rated the stock with a sell rating and four have issued a buy rating to the stock. Orthopediatrics has a consensus rating of “Hold” and a consensus price target of $23.67.

COPYRIGHT VIOLATION NOTICE: “Somewhat Positive News Coverage Somewhat Unlikely to Impact Orthopediatrics (KIDS) Share Price” was reported by Week Herald and is owned by of Week Herald. If you are reading this piece on another publication, it was illegally copied and republished in violation of US & international trademark and copyright laws. The original version of this piece can be read at https://weekherald.com/2018/02/15/somewhat-positive-news-coverage-somewhat-unlikely-to-impact-orthopediatrics-kids-share-price.html.

Orthopediatrics Company Profile

OrthoPediatrics Corp. is a medical device company. The Company designs, develops and commercializes orthopedic implants and instruments to meet the specialized needs of pediatric surgeons and their patients. It operates through the OrthoPediatrics segment, which designs, develops and markets implants and devices for children with orthopedic problems.

Insider Buying and Selling by Quarter for Orthopediatrics (NASDAQ:KIDS)

Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply